U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2001
187
Substance Class Protein
Created
by admin
on Mon Mar 31 20:37:40 GMT 2025
Edited
by admin
on Mon Mar 31 20:37:40 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMANIZED RAT
Sequence Type COMPLETE
Record UNII
3A189DH42V
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ALEMTUZUMAB (GENETICAL RECOMBINATION)
JAN  
Preferred Name English
ALEMTUZUMAB
EMA EPAR   INN   MART.   MI   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Common Name English
alemtuzumab [INN]
Common Name English
ALEMTUZUMAB [MI]
Common Name English
ALEMTUZUMAB [USAN]
Common Name English
ALEMTUZUMAB (GENETICAL RECOMBINATION) [JAN]
Common Name English
GZ402673
Code English
LDP-03
Code English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD52 (ANTIGEN)) (HUMAN-RAT MONOCLONAL CAMPATH-1H, .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Common Name English
ALEMTUZUMAB [VANDF]
Common Name English
LEMTRADA
Brand Name English
Alemtuzumab [WHO-DD]
Common Name English
ALEMTUZUMAB [PURPLE BOOK CDER]
Common Name English
RECOMBINANT HUMANISED IgG1 KAPPA ANTI-CD52 MONOCLONAL ANTIBODY ALLO-647
Common Name English
CAMPATH-1H
Common Name English
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULPHIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD52 (ANTIGEN)) (HUMAN-RAT MONOCLONAL CAMPATH-1H, .GAMMA.1-CHAIN), DISULPHIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Common Name English
GZ-402673
Code English
ALLO 647 [WHO-DD]
Common Name English
ALEMTUZUMAB [JAN]
Common Name English
ALEMTUZUMAB [MART.]
Common Name English
ALEMTUZUMAB [EMA EPAR]
Common Name English
Classification Tree Code System Code
EMA ASSESSMENT REPORTS MABCAMPTH (WITHDRAWN: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL)
Created by admin on Mon Mar 31 20:37:40 GMT 2025 , Edited by admin on Mon Mar 31 20:37:40 GMT 2025
LIVERTOX NBK548212
Created by admin on Mon Mar 31 20:37:40 GMT 2025 , Edited by admin on Mon Mar 31 20:37:40 GMT 2025
WHO-VATC QL01XC04
Created by admin on Mon Mar 31 20:37:40 GMT 2025 , Edited by admin on Mon Mar 31 20:37:40 GMT 2025
LIVERTOX NBK548212
Created by admin on Mon Mar 31 20:37:40 GMT 2025 , Edited by admin on Mon Mar 31 20:37:40 GMT 2025
EMA ASSESSMENT REPORTS LEMTRADA (AUTHORIZED: MULTIPLE SCLEROSIS)
Created by admin on Mon Mar 31 20:37:40 GMT 2025 , Edited by admin on Mon Mar 31 20:37:40 GMT 2025
NCI_THESAURUS C129822
Created by admin on Mon Mar 31 20:37:40 GMT 2025 , Edited by admin on Mon Mar 31 20:37:40 GMT 2025
FDA ORPHAN DRUG 107197
Created by admin on Mon Mar 31 20:37:40 GMT 2025 , Edited by admin on Mon Mar 31 20:37:40 GMT 2025
NDF-RT N0000175079
Created by admin on Mon Mar 31 20:37:40 GMT 2025 , Edited by admin on Mon Mar 31 20:37:40 GMT 2025
WHO-ATC L04AA34
Created by admin on Mon Mar 31 20:37:40 GMT 2025 , Edited by admin on Mon Mar 31 20:37:40 GMT 2025
NDF-RT N0000175659
Created by admin on Mon Mar 31 20:37:40 GMT 2025 , Edited by admin on Mon Mar 31 20:37:40 GMT 2025
WHO-ATC L01XC04
Created by admin on Mon Mar 31 20:37:40 GMT 2025 , Edited by admin on Mon Mar 31 20:37:40 GMT 2025
NCI_THESAURUS C72960
Created by admin on Mon Mar 31 20:37:40 GMT 2025 , Edited by admin on Mon Mar 31 20:37:40 GMT 2025
Code System Code Type Description
EVMPD
SUB12459MIG
Created by admin on Mon Mar 31 20:37:40 GMT 2025 , Edited by admin on Mon Mar 31 20:37:40 GMT 2025
PRIMARY
USAN
LL-56
Created by admin on Mon Mar 31 20:37:40 GMT 2025 , Edited by admin on Mon Mar 31 20:37:40 GMT 2025
PRIMARY
MESH
C096529
Created by admin on Mon Mar 31 20:37:40 GMT 2025 , Edited by admin on Mon Mar 31 20:37:40 GMT 2025
PRIMARY
CAS
216503-57-0
Created by admin on Mon Mar 31 20:37:40 GMT 2025 , Edited by admin on Mon Mar 31 20:37:40 GMT 2025
PRIMARY
LACTMED
Alemtuzumab
Created by admin on Mon Mar 31 20:37:40 GMT 2025 , Edited by admin on Mon Mar 31 20:37:40 GMT 2025
PRIMARY
MERCK INDEX
m1492
Created by admin on Mon Mar 31 20:37:40 GMT 2025 , Edited by admin on Mon Mar 31 20:37:40 GMT 2025
PRIMARY Merck Index
DRUG CENTRAL
4909
Created by admin on Mon Mar 31 20:37:40 GMT 2025 , Edited by admin on Mon Mar 31 20:37:40 GMT 2025
PRIMARY
DRUG BANK
DB00087
Created by admin on Mon Mar 31 20:37:40 GMT 2025 , Edited by admin on Mon Mar 31 20:37:40 GMT 2025
PRIMARY
SMS_ID
100000089882
Created by admin on Mon Mar 31 20:37:40 GMT 2025 , Edited by admin on Mon Mar 31 20:37:40 GMT 2025
PRIMARY
DAILYMED
3A189DH42V
Created by admin on Mon Mar 31 20:37:40 GMT 2025 , Edited by admin on Mon Mar 31 20:37:40 GMT 2025
PRIMARY
FDA UNII
3A189DH42V
Created by admin on Mon Mar 31 20:37:40 GMT 2025 , Edited by admin on Mon Mar 31 20:37:40 GMT 2025
PRIMARY
INN
8005
Created by admin on Mon Mar 31 20:37:40 GMT 2025 , Edited by admin on Mon Mar 31 20:37:40 GMT 2025
PRIMARY
HSDB
8177
Created by admin on Mon Mar 31 20:37:40 GMT 2025 , Edited by admin on Mon Mar 31 20:37:40 GMT 2025
PRIMARY
IUPHAR
6770
Created by admin on Mon Mar 31 20:37:40 GMT 2025 , Edited by admin on Mon Mar 31 20:37:40 GMT 2025
PRIMARY
WIKIPEDIA
ALEMTUZUMAB
Created by admin on Mon Mar 31 20:37:40 GMT 2025 , Edited by admin on Mon Mar 31 20:37:40 GMT 2025
PRIMARY
NCI_THESAURUS
C1681
Created by admin on Mon Mar 31 20:37:40 GMT 2025 , Edited by admin on Mon Mar 31 20:37:40 GMT 2025
PRIMARY
ChEMBL
CHEMBL1201587
Created by admin on Mon Mar 31 20:37:40 GMT 2025 , Edited by admin on Mon Mar 31 20:37:40 GMT 2025
PRIMARY
RXCUI
117055
Created by admin on Mon Mar 31 20:37:40 GMT 2025 , Edited by admin on Mon Mar 31 20:37:40 GMT 2025
PRIMARY RxNorm
From To
1_22 1_98
1_148 1_204
1_224 3_214
1_230 2_230
1_233 2_233
1_265 1_325
1_371 1_429
2_22 2_98
2_148 2_204
2_224 4_214
2_265 2_325
3_23 3_88
3_134 3_194
4_23 4_88
4_134 4_194
2_371 2_429
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_301
N 2_301
Related Record Type Details
CAMPATH-1 ANTIGEN
TARGET -> INHIBITOR
HIGH AFFINITY IMMUNOGLOBULIN GAMMA FC RECEPTOR I
TARGET -> AGONIST
ALEMTUZUMAB
TARGET -> INHIBITOR
Related Record Type Details
ALEMTUZUMAB
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:ESTIMATED CHEMICAL
Volume of Distribution PHARMACOKINETIC
Molecular Formula CHEMICAL
Biological Half-life PHARMACOKINETIC
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966